#AI drug discovery

Total 3 articles

The $1.3B Signal: Chai Discovery Isn't Just Another Biotech Unicorn, It's a Bet on Re-platforming Pharma

Chai Discovery's $1.3B valuation isn't just funding; it's a bet on 'Generative Biology.' Our analysis explores the impact on pharma R&D and investors.

Dec 17, 2025

TechEN

Chai Discovery's $1.3B Valuation Isn't About Drugs—It's About the AI Platform Wars Invading Biotech

Chai Discovery's $130M raise at a $1.3B valuation isn't about a single drug. It's a strategic move by OpenAI's ecosystem to build the dominant AI platform for biotech.

Dec 16, 2025

TechEN

Chai Discovery's $1.3B Valuation Isn't About Drugs—It's About the AI Platform Wars Invading Biotech

Chai Discovery's $130M raise at a $1.3B valuation isn't about a single drug. It's a strategic move by OpenAI's ecosystem to build the dominant AI platform for biotech.

Dec 16, 2025

PRISM by Liabooks

PRISM

Advertise with Us

Place your ad in this space

[email protected]